key: cord-0859932-mkkind1m
authors: Juaneda, Ernesto; Catalfamo, Danilo; Fregapani, Juan P.; Peirone, Alejandro; Juaneda, Ignacio; Kreutzer, Cristian; Lucino, Sergio
title: Magnetic resonance lymphangiography in group 1 paediatric pulmonary arterial hypertension
date: 2021-03-30
journal: Pulm Circ
DOI: 10.1177/20458940211004777
sha: 16e4e1b0a231a21828fa2a3b08677328802a90fe
doc_id: 859932
cord_uid: mkkind1m

Pulmonary hypertension could have thoracic lymphatic abnormalities caused by right ventricular failure. Since there is no description of such abnormalities, the purpose of this study was to investigate them with magnetic resonance. Prospective review magnetic resonance T2-weighted lymphangiography was performed between January 2017 and October 2019 through quantitative thoracic duct diameter, diameter index and qualitative lymphatic abnormalities types: 1 – little or none abnormalities, 2 – abnormalities in supraclavicular region, 3 – abnormalities extending into the mediastinum and 4 – abnormalities extending into the lung. Five patients with group 1 pulmonary arterial hypertension participated in this study. The mean age was 12.44 ± 4.92 years, three male and two female. The quantitative analysis yielded the following results: mean thoracic duct diameter of 2.92 ± 0.16 mm and thoracic duct index 2.28 ± 1.03 mm/m(2). Qualitative lymphangiography abnormalities were type 1 in three patients, type 2 in one, all with low-risk determinants, and type 3 in one with high-risk determinants and right ventricular failure. Magnetic resonance T2-weighted lymphangiography in group 1 paediatric pulmonary arterial hypertension allowed for the identification of the thoracic duct, which was used to perform both quantitative and qualitative analysis of thoracic lymphatic abnormalities, in particular when increased high-risk determinants and right ventricular failure were present. These features represent an extracardiac finding useful to understand systemic venous congestion impact on lymphatic system.

Five paediatric patients with confirmed pulmonary arterial hypertension (PAH) were consecutively scanned with magnetic resonance T2-weighted lymphangiography for a period of 2 years and 10 months between January 2017 and October 2019, after Ethical Committee approval and informed consent forms collected. 1, 2 The purpose of such scanning was to describe thoracic duct (TD) and lymphatic abnormalities through T2-weighted cardiac magnetic resonance (CMR) lymphangiography with quantitative and qualitative data. Three patients were male and two female with mean age of 12.44 AE 4.92 (6.7-19) years. Three had idiopathic PAH, one was diagnosed with hereditary/familiar PAH and one had PAH congenital heart disease (CHD) with persistent PAH after patent ductus arteriosus surgical repair. We reviewed existing clinical data including paediatric Functional Class (FC), six-minute walk test (6MWT), nterminal pro-b-type natriuretic peptide, specific pulmonary hypertension (PH) treatment and risk determinants. 1 Acquisition of CMR images was performed on a 3-Tesla scanner (Siemens Magneton Spectra -Erlanger, Germany), with a six-channel body coil, with ECG gating and respiratory navigator, without sedation/general anaesthesia or external contrast agent enhancement. One patient, on subcutaneous treprostinil, required pump disconnection while performing CMR. Image acquisition started with T1weigthed anatomical thoracic orthogonal planes followed by coronal lymphangiography acquisition T2-weighted space steer sequence with respiratory navigator that enabled free breathing, repetition time/echo time 2500/650 ms, flip angle of 140 and voxel size of 1.1 Â 1.1 Â 1.1.4 mm for TD acquisition imaging in 4-6 min. 2 Finaly, True FISP sequence real time cineangiography (GRAPPA, Siemens) was used to obtain right ventricle (RV) and left ventricle (LV) ejection fraction through two-dimensional reoriented short axis multi-sections. 4 This methodology allowed us to perform CMR without breath hold, anaesthesia or external contrast enhancement on these fragile PAH paediatric patients.

Post-processing, CMR was performed on a dedicated workstation (SyngoMR-Argus, Siemens) with a 1280-pixelsquare-inch-resolution screen according to recommended report standardization. 5 The CMR T2 lymphangiography TD quantification was done through major intensity projection (2D MIP) diameter (mm) and indexed to surface area (mm/m 2 ) on magnified image of three average measurements at thoracic vertebra 1 or 2 level. Means and standard deviations were calculated and yielded the following values as shown on Table 1 . The CMR T2 lymphangiography 2D MIP mean TD diameter was 2.92 AE 0.16 mm and the mean TD index was 2.28 AE 1.03 mm/m 2 . Qualitative analysis was performed through three-dimensional volume rendered (3D VR) lymphatic reconstruction in order to establish lymphatic abnormality type: Type 1 -little or none, Type 2 -in supraclavicular region, Type 3 -extending into the mediastinum and Type 4 -extending into the lung. 2 The qualitative 3D VR abnormalities were Type 1 in three patients, Type 2 in one and Type 3 in one (Table 1) . CMR real-time cineangiography mean RV ejection fraction was 56.6 AE 9.02% and the mean LV ejection fraction was 64.2 AE 8.35% as shown on Table 1 as well. CMR T2 lymphatic abnormality Type 3 was present in the patient with increased NT-pro BNP, and 40% RV ejection fraction as part of high risk determinants (Fig. 1) . These findings could be attributed to RV failure. The quantitative and qualitative analyses were performed by one CMR specialist (E.J., 24 years of experience). Limitations of this study are small number of patients due to low incidence of PAH in paediatric population and lack of genetic study.

Imaging PH modalities include chest radiography, echocardiography, nuclear medicine, computed tomography, CMR and CC angiography. 6-8 CMR has evolved into a gold standard of non-invasive imaging tool in cardiovascular medicine, especially for visualizing and quantifying heart anatomy, volume, function and myocardial tissue characterization. 6 CMR T2-weighted lymphatic abnormalities were initially described after Fontan/Kreutzer cavopulmonary anastomosis, and recently, CMR T2 lymphangiography proved its utility before that procedure if a lymphatic Hraska decompression was necessary when lymphatic abnormality Type III or IV were present. 2, 9 PAH patients have RV afterload chronically increased and are at risk of developing RV failure. When RV failure occurs, right atrium and systemic venous pressure increases. As TD drains into systemic left jugular subclavian vein, patients with PAH with high-risk determinants and RV failure may have lymphatic abnormality not previously described with CMR T2 lymphangiography.

Magnetic resonance T2-weighted lymphangiography in group 1 paediatric PAH allowed for the identification of the TD, which was used to perform both quantitative and qualitative analyses of thoracic lymphatic abnormalities, in particular when increased high-risk determinants and RV failure were present. These features represent an additional extra cardiac finding useful to understand systemic venous congestion impact on the lymphatic system.

Written informed consent to participate was obtained in all patients.

All authors signed a consent for publication.

The author(s) declare that there is no conflict of interest.

Local Institutional Ethic and Research Committee of Child and Adults statement accepted this research protocol due to the characteristic of this study (observational and prospective).

Not applicable.

Author contribution E.J.: study conception, design, analysis, interpretation of data and drafting of manuscript; D.C. and J.P.F.: acquisition of data; A.P., I.J., C.K. and S.L.: critical revisi on; all authors approved the final versi on of the manuscript.

This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. 

Paediatric pulmonary arterial hypertension: updates on definition, classification, diagnostics and management

MRI of lymphatic abnormalities after funtional single ventricle palliation surgery

Functional classification of pulmonary hypertension in children: report from the PVRI pediatric taskforce

Real-time assessment of right and left ventricular volumes and function in patients with congenital heart disease by using high spatiotemporal resolution radial k-t SENSE1

Standardized image interpretation and postprocessing in cardiovascular magnetic resonance -2020 update Society for Cardiovascular Magnetic Resonance (SCMR

Statement on imaging and pulmonary hypertension from the Pulmonary Vascular Research Institute (PVRI)

Cardiac MR and CT imaging in children with suspected or confirmed pulmonary hypertension/pulmonary hypertensive vascular disease. Expert Fig. 1. Thoracic coronal section with sagittal angulation of T2-weighted lymphangiography, 3D volume rendered (VR) qualitative lymphatic abnormality Type 3 with lymphangiectasia on left supraclavicular area (left upper horizontal arrow), thoracic duct (left middle horizontal arrow), mediastinal lymphangiectasia (left bottom horizontal arrow) and spine

7-year-old female patient with IPAH, FC IIIb, unable to perform 6MWT, NT pro-BNP 1887 pg/ml, mPAP 51 mmHg, PVRI 6.8 WU.m 2 , TD diameter 3 mm, TD index 4 mm/m2, RV EF 40%, on sildenafil, bosentan and subcutaneous treprostinil

The authors are indebted to Maria del Mar Ferrer for her valuable references assistance during COVID-19 outbreak.

Ernesto Juaneda https://orcid.org/0000-0002-8939-1153